These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: [Clinical application of radiofrequency ablation]. Author: Hu DY. Journal: Zhonghua Xin Xue Guan Bing Za Zhi; 1992 Aug; 20(4):207-9, 259. PubMed ID: 1304486. Abstract: UNLABELLED: I. Radiofrequency ablation of atrioventricular accessory pathway in patients with WPW syndrome: Seventeen accessory pathways in 15 patients with Wolff-Parkinson-White syndrome (WPW) were ablated with radiofrequency current. There were 15 accessory pathways located on the left side of the heart (12 left free wall, 1 posterioseptal, 1 posteriolateral and 1 midseptal) and 2 pathways on the right side (1 right free wall, 1 anterioseptal). 16 accessory pathways (94.1%) in 14 patients were permanently abolished. Plasma CK-Mb, SGOT and LDH increased moderately in 7 cases (46.7%) and decreased to normal level in 3-4 days. CONCLUSION: catheter ablation of accessory pathways with radiofrequency current is a safe and effective therapeutic method for patients with refractory tachycardias mediated by these pathways. II. Radiofrequency ablation of slow pathways to cure AV nodal reentrant tachycardia: Radiofrequency energy was used to selectively ablate the slow pathways in 8 patients with atrioventricular nodal reentrant tachycardia. The slow pathways in all 8 cases were ablated successfully and no episodes of tachycardia could be induced. The A-H, H-V interval and P-R interval of ECG did not change significantly. The Wenckebach points of atrioventricular node remained unchanged. The effective refractory periods of the fast pathways were shortened in 3 and prolonged in 5 cases after the procedure. There were no severe complications. No tachycardia recurred during the follow-up period between 2 weeks and 7 months.[Abstract] [Full Text] [Related] [New Search]